Locals Release 10 Endangered Siamese Crocodiles into Laos Wetlands to Save Species from Extinction

One of the Siamese crocodiles released – credit Phetpakay Bounhaxay © WCSWhile less than 1,000 Siamese crocodiles remain in the wild, community members in Laos have released ten of the rare animals into a local wetlands to boost the population.While crocodiles are not hunted, the species (Crocodylus siamensis) is ranked as Critically-Endangered by the International Union for Conservation of Nature because of the threats of entanglement in fishing nets, the clearance of wetlands, and seasonal draining of habitat to expand dry-season rice cultivation.Unlike many of its other aggressive cousins, the Siamese crocodile is not a threat to humans. Communities that reside close to the species’ habitat hold the crocodiles in high regard spiritually—believing they bring good luck.The Xe Champhone Wetland where they were released is located in the Savannakhet province which represents the larger of two ‘Ramsar sites’ (Wetland of International Importance).It’s home to an abundance of aquatic biodiversity such as endangered turtle species and waterfowl.A dedicated conservation program for the Siamese crocodile is in place in the four target districts where they’re found. Volunteers work with government officials and eggs are collected to be transported to the village administration office for incubation at ambient temperature for about two months.Once...
Read More........

Japan to Begin Clinical Trials for Artificial Blood This Year

credit – Adrian Sulyok on UnsplashJapan is the first country to begin clinical trials of artificial blood, a medical innovation which if proven successful, would solve one of the largest hospital challenges of our age.Beginning back in March, a clinical trial organized by Nara Medical University will look to build on the success of an early-stage trial in 2022 of hemoglobin vesicles, small artificial blood cells that were confirmed to be safe and capable of delivering oxygen as normal.The trial will administer 100 to 400 milliliters of the artificial blood cells to further test safety before moving onto broader performance and efficacy targets, all in the hopes that by 2030, the artificial blood could enter clinical use.Whether high-income or low-income, every country has challenges meeting the necessity necessary amounts of stockpiled blood donations for emergency medical procedures.In high-income countries where the 90% of blood stockpiles comes from voluntary donors, the challenge is getting enough of these donations, and crucially, enough from those with rare blood types.In low-income countries where only 40% of needs are met with donations, the challenge lies in importation from abroad when donated blood packs are only safe for use for a few months. A useful proxy to understanding this shortfall is that of 175 countries included...
Read More........